SIBO - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Opiate Receptor Drugs – To Cycle or Not to Cycle Dosing? - Paul Anderson, NMD (2021 Conference) (LDN, low dose naltrexone)

Restless Leg Syndrome - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

This lecture starts with the known and newer pathophysiology to try to uncover new ways of treating restless legs syndrome (RLS). Using case studies, he links RLS with small intestinal bacterial overgrowth (SIBO), low iron, and other autoimmune disorders. Treatment examples are provided

Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Drug Resistant Depression - Elizabeth Livengood, NMD (2021 Conference) (LDN, low dose naltrexone)

Dr. Elizabeth Livengood’s presentation is on identifying different causes of depression, identifying depression, hyperthyroidism connections, identifying patient profiles who fit these descriptions, and understanding how to treat them. 

History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Jill Cottel, MD - Vitamin D and Autoimmune Disease: A Systematic Review of the Literature (2017 Conference) (LDN, low dose naltrexone)

Ginevra Liptan, MD - Alternative Strategies for Fibromyalgia Pain (2017 Conference) (LDN, low dose naltrexone)

Yoon Hang "John" Kim, MD - Treating chronic pain with low dose naltrexone and ultra low dose naltrexone (2019 Conference) (LDN, low dose naltrexone)

Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Tara Thompson, PharmD discusses the purpose of a compounding pharmacy, how to choose one, the benefits and limitations of compounding, and dosage forms. She give an overview of naltrexone, dosing of LDN in various conditions, and how to write a prescription for compounded naltrexone.